PanB over-representation as part of pyrazinamide action: a proteomic insight

Future Microbiol. 2021 Nov:16:1303-1308. doi: 10.2217/fmb-2020-0307. Epub 2021 Nov 8.

Abstract

Background: Pyrazinamide (PZA) represents a milestone as a first-line antituberculosis drug due to its sterilizing activity against Mycobacterium tuberculosis. Materials & Methods: The protein changes induced by subinhibitory PZA exposure of M. tuberculosis in acidic pH were evaluated by a proteomic approach. Results: Among the 1059 M. tuberculosis proteins identified, the specific acidification in the culture medium induced the over-representation of MurF (Rv2157c), and its under-representation was induced by 12 h of PZA exposure. PanB (Rv2225) was over-represented at 24 h of PZA exposure. Conclusion: The authors highlight the over-representation of PanB in M. tuberculosis correlates of PZA action in acidic pH, reinforcing the role of the pantothenate pathway as a bacillus drug target to be explored.

Keywords: Mycobacterium tuberculosis; drug targets; proteomics; pyrazinamide; tuberculosis.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antitubercular Agents / pharmacology
  • Drug Resistance, Bacterial
  • Humans
  • Microbial Sensitivity Tests
  • Mycobacterium tuberculosis* / metabolism
  • Proteomics
  • Pyrazinamide / pharmacology
  • Tuberculosis* / drug therapy
  • Tuberculosis* / microbiology

Substances

  • Antitubercular Agents
  • Pyrazinamide